How a Weight Loss Shot Changes Your Brain’s Reaction to Food

Original Title

Longer‐term liraglutide administration at the highest dose approved for obesity increases reward‐related orbitofrontal cortex activation in response to food cues: Implications for plateauing weight loss in response to anti‐obesity therapies

Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms

Summary

This study looked at how a medicine called liraglutide, used for weight loss, affects the brain when people see food. It found that after 5 weeks, people lost weight and their brains reacted differently to food pictures — but only when we account for the weight they lost.

Sign up to see full results

Get access to research results, context, and detailed analysis.

Surprising Findings

Liraglutide increased brain activity in the reward center when adjusted for weight loss—opposite to expected suppression.

Most assumed GLP-1 drugs reduce food reward signaling. This shows the brain may actually amplify reward signals as a defense against weight loss, a 'counter-regulatory' response.

Practical Takeaways

If you're on a GLP-1 drug and hit a weight loss plateau, it may not be your fault—your brain could be pushing back.

medium confidence

Unlock Full Study Analysis

Sign up free to access quality scores, evidence strength analysis, and detailed methodology breakdowns.

66%
Moderate QualityOverall Score

Publication

Journal

Diabetes

Year

2019

Authors

Olivia M. Farr, J. Upadhyay, Chelsea Rutagengwa, Bridget DiPrisco, Zachary Ranta, Amal Adra, Neha Bapatla, V. P. Douglas, K. Douglas, Eric Nolen-Doerr, H. Mathew, C. Mantzoros

Open Access
51 citations
Analysis v1